These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1676055)

  • 41. Heterogeneity of D2 dopamine receptors in different brain regions.
    Leonard MN; Macey CA; Strange PG
    Biochem J; 1987 Dec; 248(2):595-602. PubMed ID: 2963621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of flunarizine with dopamine D2 and D1 receptors.
    Ambrosio C; Stefanini E
    Eur J Pharmacol; 1991 May; 197(2-3):221-3. PubMed ID: 1833208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of thiol groups in ligand binding to D2 dopamine receptors from brain and anterior pituitary gland.
    Chazot PL; Strange PG
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):377-80. PubMed ID: 1736887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine receptor subtype imbalance in schizophrenia.
    Hess EJ; Bracha HS; Kleinman JE; Creese I
    Life Sci; 1987 Apr; 40(15):1487-97. PubMed ID: 2951573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
    Schulz DW; Stanford EJ; Wyrick SW; Mailman RB
    J Neurochem; 1985 Nov; 45(5):1601-11. PubMed ID: 2864398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH
    Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide.
    Grigoriadis D; Seeman P
    J Neurochem; 1985 Jun; 44(6):1925-35. PubMed ID: 3157782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G; Titeler M
    Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
    Lever JR; Scheffel UA; Stathis M; Musachio JL; Wagner HN
    Life Sci; 1990; 46(26):1967-76. PubMed ID: 2362552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activity of N-(2-phenylethyl)-N-n-propyl-2-(3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands.
    Claudi F; Cardellini M; Di Stefano A; Giorgioni G; Cantalamessa F; Renò F; Balduini W
    Drug Des Discov; 1994 Feb; 11(2):115-25. PubMed ID: 7915549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice.
    Rubinstein M; Muschietti JP; Gershanik O; Flawia MM; Stefano FJ
    J Pharmacol Exp Ther; 1990 Feb; 252(2):810-6. PubMed ID: 2138223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative autoradiographic localization of central dopamine D-1 and D-2 receptors.
    Dawson TM; Gehlert DR; Wamsley JK
    Adv Exp Med Biol; 1986; 204():93-118. PubMed ID: 2947431
    [No Abstract]   [Full Text] [Related]  

  • 53. Modulation of dopamine uptake in rat nucleus accumbens: effect of specific dopamine receptor antagonists and sigma ligands.
    Thompson TL; Bridges S; Miller C
    Neurosci Lett; 2001 Oct; 312(3):169-72. PubMed ID: 11602337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of cholesterol on synaptic fluidity, dopamine D1 binding and dopamine-stimulated adenylate cyclase.
    Maguire PA; Druse MJ
    Brain Res Bull; 1989; 23(1-2):69-74. PubMed ID: 2529953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localized alterations of dopamine receptor binding in rat brain by repeated electroconvulsive shock: an autoradiographic study.
    Barkai AI; Durkin M; Nelson HD
    Brain Res; 1990 Oct; 529(1-2):208-13. PubMed ID: 2149297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study.
    Cagnotto A; Parotti L; Mennini T
    Eur J Pharmacol; 1996 Oct; 313(1-2):63-7. PubMed ID: 8905329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-activity relationships of N-n-propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine derivatives as dopamine receptor ligands.
    Claudi F; Giorgioni G; Di Stefano A; Renò F; Balduini W
    Drug Des Discov; 1992; 9(2):155-66. PubMed ID: 1296798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy.
    Andersen PH; Jansen JA
    Eur J Pharmacol; 1990 Jun; 188(6):335-47. PubMed ID: 1973652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: a quantitative autoradiographic study.
    Przedborski S; Kostic V; Jackson-Lewis V; Cadet JL; Burke RE
    J Neurochem; 1991 Dec; 57(6):1951-61. PubMed ID: 1834800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Affinity shifts induced by cations do not reliably predict the agonistic or antagonistic nature of ligands at brain dopamine receptors.
    Urwyler S
    J Neurochem; 1987 Nov; 49(5):1415-20. PubMed ID: 2959751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.